Tifcemalimab
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Tifcemalimab, covering 2024-06-21 to 2024-12-27. Get the full timeline:
Most recent: Clinical Trial Update: Low-dose Radiotherapy Combined with Concurrent Chemotherapy, Toripalimab and Tifcemalimab in the Treatment of ES-SCLC [Phase 1]